Switch to:
Bio-Reference Laboratories Inc (NAS:BRLI)
Cash Flow for Capital Expenditures
$-15.5 Mil (TTM As of Oct. 2014)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Bio-Reference Laboratories Inc's cash flow for capital expenditures for the three months ended in Oct. 2014 was $-4.5 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Oct. 2014 was $-15.5 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Bio-Reference Laboratories Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Oct. 2014 was -2.771 (Jan. 2014 ) + -4.277 (Apr. 2014 ) + -4.018 (Jul. 2014 ) + -4.457 (Oct. 2014 ) = $-15.5 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Bio-Reference Laboratories Inc Annual Data

Oct05Oct06Oct07Oct08Oct09Oct10Oct11Oct12Oct13Oct14
Cash Flow_CPEX -2.9-2.9-7.8-8.0-8.9-16.5-14.1-15.7-25.1-15.5

Bio-Reference Laboratories Inc Quarterly Data

Jul12Oct12Jan13Apr13Jul13Oct13Jan14Apr14Jul14Oct14
Cash Flow_CPEX -1.7-4.4-4.8-5.8-7.0-7.5-2.8-4.3-4.0-4.5
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK